NeuroTherapia, Inc.
PrivateLast Round
Series B
Aug 6, 2024
Total Funding Raised
$11.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
NeuroTherapia, Inc. is a clinical-stage biotechnology company developing oral, small-molecule drugs to address neuro-inflammatory conditions of the central nervous system, including Alzheimer's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroTherapia, Inc. Comparables
Compare NeuroTherapia, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cerevance | 82% | |
| Tranquis Therapeutics | 82% | |
| Neusignal Therapeutics, Inc. | 81% |
NeuroTherapia, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 6, 2024 | ||||
| Series A | Sep 22, 2020 | ||||
| Grant | Sep 21, 2016 | ||||
| Seed | Oct 13, 2015 |
Key People
Founding team and executive leadership
NeuroTherapia, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Brain Trust Accelerator Fund | Series B, Series A |
| Dolby Family Ventures | Series B, Series A |
| Cleveland Clinic Ventures | Series B, Series A |
| The Foundation For A Better World | Series B |
| Alzheimer's Drug Discovery Foundation | Series B, Series A, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 228% MoM, reaching 1K.
- Aug 6, 2024
$12M round led by Cleveland Clinic
Recent news
Latest coverage and updates
- attends_eventJul 13, 2026
NeuroTherapia, Inc. attended event AAIC 2026 Conference on Jul 13th '26.
- attends_eventJul 13, 2026
NeuroTherapia, Inc. attended event Alzheimer's Association International Conference (AAIC) 2026 on Jul 13th '26.
NeuroTherapia, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NeuroTherapia, Inc.'s valuation, stock price, and market status.
Is NeuroTherapia, Inc. a public or private company?
NeuroTherapia, Inc. is a private company.
What is the current stock price of NeuroTherapia, Inc.?
NeuroTherapia, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is NeuroTherapia, Inc. worth (valuation)?
Valuation information for NeuroTherapia, Inc. is not publicly available.
Can I buy NeuroTherapia, Inc. stock?
NeuroTherapia, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was NeuroTherapia, Inc.'s last funding round?
NeuroTherapia, Inc.'s most recent funding round was Series B on August 6, 2024.
Who are the main investors in NeuroTherapia, Inc.?
Key investors in NeuroTherapia, Inc. include Brain Trust Accelerator Fund.
Will NeuroTherapia, Inc. IPO soon?
No public IPO plans have been announced for NeuroTherapia, Inc..
How can I track NeuroTherapia, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NeuroTherapia, Inc.'s secondary market activity and sign up for updates.